SCHEMBL845566

SCHEMBL845566

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3cccc4c3Cc3ccccc3-4)cc2)cc1)[C@@H]1CCCN1C(=O)c1cccc2c1Cc1ccccc1-2

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
TRPV1 Q8NER1 1/20 0.42
MAPK1 P28482 2/20 0.41
HTT P42858 1/20 0.41
MAPT P10636 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
RHOC P08134 1/20 0.40
RHOA P61586 1/20 0.40
PABPC1 P11940 1/20 0.39
LMNA P02545 1/20 0.39
EP300 Q09472 1/20 0.39
CREBBP Q92793 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10119642 0.92 HDAC3 (0.40) ALDH1A1CYP2C9CYP2C19TRPV1MAPK1
SCHEMBL845349 0.85 HCRTR1 (0.53) ALDH1A1CYP2C9CYP2C19TRPV1MAPK1
SCHEMBL845008 0.81 ALDH1A1 (0.54) ALDH1A1CYP2C9CYP2C19MAPK1HTT
SCHEMBL845039 0.81 TRPV1 (0.51) ALDH1A1CYP2C9CYP2C19TRPV1MAPK1
SCHEMBL845761 0.81 CYP2C9 (0.42) ALDH1A1CYP2C9CYP2C19TRPV1MAPK1
SCHEMBL845257 0.81 TRPV1 (0.48) ALDH1A1CYP2C9CYP2C19TRPV1MAPK1
SCHEMBL844996 0.81 CYP2C9 (0.50) ALDH1A1CYP2C9CYP2C19TRPV1MAPK1
SCHEMBL845443 0.81 CYP2C9 (0.47) ALDH1A1CYP2C9CYP2C19TRPV1MAPK1
SCHEMBL845450 0.79 ALDH1A1 (0.46) ALDH1A1CYP2C9CYP2C19TRPV1MAPK1
SCHEMBL845007 0.79 PABPC1 (0.49) ALDH1A1CYP2C9CYP2C19TRPV1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed